cp wire

CP Wire Articles

Catabasis Plans Ph III Trial for Edasalonexent in Duchenne Muscular Dystrophy
  • Plans to initiate trial in second half of 2018
  • Edasalonexent significantly slowed progression in Ph II trial
  • Edasalonexent is being developed as monotherapy or for use in... read more
Mon, 07/9/18 - 09:04 am
BioGaia Purchases Additional 30% Stake in Microbiome Company MetaboGen

On April 6, 2018, BioGaia became the majority shareholder in MetaboGen with a 62 percent stake. After certain milestones were achieved, BioGaia has extended its ownership to 92 percent of the... read more

Fri, 07/6/18 - 11:49 am
SIGA Technologies Publishes Positive Data For Its Oral Small Pox Vaccine
  • There is concern that smallpox could be used as a bioweapon
  • TPOXX was effective in animal models
  • Target PDUFA date is August 8, 2018

SIGA Technologies,... read more

Thu, 07/5/18 - 09:02 am
Walgreens Boots Alliance Completes Investment in Chinese Pharmacy Chain

Walgreens Boots Alliance, Inc. (Nasdaq: WBA) today announced that, following receipt of regulatory approvals, it has completed the previously announced agreement to acquire a 40 percent minority... read more

Thu, 07/5/18 - 08:46 am
Eagle Pharmaceuticals Receives New Patent for Bendeka
  • Bendeka has Orphan Drug Exclusivity until Dec. 2022
  • Company does not expect generic entrants of previous version of Bendeka until Dec. 2022
  • Teva is responsible for all US... read more
Tue, 07/3/18 - 09:54 am

Pages